CDK5 Antikörper (N-Term)
Kurzübersicht für CDK5 Antikörper (N-Term) (ABIN925902)
Target
Alle CDK5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Hund, Zebrafisch (Brachydanio rerio), Rind (Kuh), Schwein, Huhn
-
Immunogen
- CDK5 antibody was raised in rabbit using the N terminal of CDK5 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CDK5 Blocking Peptide, (ABIN5612791), is also available for use as a blocking control in assays to test for specificity of this CDK5 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CDK5 (Cyclin-Dependent Kinase 5 (CDK5))
-
Andere Bezeichnung
- CDK5
-
Hintergrund
- CDK5 is probably involved in the control of the cell cycle. CDK5 can interact with d1 and d3-type G1 cyclins and phosphorylate histone H1, tau, MAP2 and NF-H and NF-M. CDK5 can also interacts with p35 which activates the kinase. Synonyms: Polyclonal CDK5 antibody, Anti-CDK5 antibody, cyclin-dependent kinase 5 antibody.
-
Pathways
- Zellzyklus, Regulation of Muscle Cell Differentiation, Synaptic Membrane, Regulation of Cell Size, Skeletal Muscle Fiber Development, Synaptic Vesicle Exocytosis
Target
-